Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole vs Risperidone in Refractory OCD
NCT05401019Phase 2Withdrawn
- Sponsor
- Clinical Academic Center
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pramipexole in obsessive compulsive disorder (OCD), sponsored by Clinical Academic Center. Planned start Jun 2022; status: withdrawn.
02
Drugs
pramipexole
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT05401019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05401019.